STOCK TITAN
  1. Home
  2. Sec-filings
  3. RBA
  4. [Form 4] RB Global, Inc. Insider Trading Activity

Routine Insider Accrual: RBA Director Receives 20 Rights on 06/20/25

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

RB Global, Inc. (RBA) – Form 4 insider transaction filing

Director Brian A. Bales reported three routine, no-cost acquisitions of dividend-equivalent rights on 20 June 2025. The derivative rights accrued automatically on previously granted deferred share units (DSUs) and restricted share units (RSUs) and convert into common shares on the same schedule as the underlying units.

  • 7 dividend-equivalent rights tied to outstanding DSUs (underlying 7 common shares; beneficial holdings of this class now 46)
  • 8 dividend-equivalent rights tied to the 2024 RSU grant (underlying 8 common shares; holdings now 42)
  • 5 dividend-equivalent rights tied to the 2025 RSU grant (underlying 5 common shares; first reported position)

The transactions were coded “A” (acquisition) and are recorded as direct ownership. No dispositions, open-market purchases, or sales were reported, and no cash consideration was paid. These incremental awards are mechanically generated by the company’s dividend policy and are typical for equity-based compensation programs. Given the small number of underlying shares (total 20) and their origin as dividend adjustments, the filing is considered routine with minimal impact on the company’s share float or governance profile.

Positive

  • None.

Negative

  • None.

Insights

TL;DR – Routine, immaterial insider accrual of 20 dividend-equivalent rights; negligible impact.

The filing shows automatic crediting of dividend-equivalent rights to Director Brian Bales’ existing DSU and RSU balances. Because the rights vest and convert only when the underlying DSUs/RSUs vest, today’s disclosure does not alter immediate share count or insider ownership meaningfully. No cash changed hands, signaling the event is purely mechanical under the compensation plan. Investors generally view such micro-adjustments as administratively necessary rather than sentiment-driven.

Insider Bales Brian A
Role Director
Type Security Shares Price Value
Grant/Award Dividend Equivalent Rights (DSUs) 7 $0.00 --
Grant/Award Dividend Equivalent Rights (2024 RSUs) 8 $0.00 --
Grant/Award Dividend Equivalent Rights (2025 RSUs) 5 $0.00 --
Holdings After Transaction: Dividend Equivalent Rights (DSUs) — 46 shares (Direct); Dividend Equivalent Rights (2024 RSUs) — 42 shares (Direct); Dividend Equivalent Rights (2025 RSUs) — 5 shares (Direct)
Footnotes (1)
  1. The dividend equivalent rights accrued in respect of the reporting person's deferred share units, and become exercisable and payable concurrently with the deferred share units. Each dividend equivalent right represents a contingent right to receive the economic equivalent of one RBA common share. Each dividend equivalent right represents a contingent right to receive the economic equivalent of one RBA common share. The dividend equivalent rights accrued in respect of the 2024 grant of restricted share units (RSU), and become exercisable proportionately with the restricted share units to which they relate. Each dividend equivalent right represents a contingent right to receive the economic equivalent of one RBA common share. The dividend equivalent rights accrued in respect of the 2025 grant of restricted share units (RSU), and become exercisable proportionately with the restricted share units to which they relate.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Bales Brian A
(Last) (First) (Middle)
C/O RB GLOBAL, INC.
2 WESTBROOK CORPORATE CENTER
(Street)
WESTCHESTER IL 60154
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
RB GLOBAL INC. [ RBA ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
06/20/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Dividend Equivalent Rights (DSUs) (1) 06/20/2025 A 7 (1) (1) Common Shares 7 $0 46 D
Dividend Equivalent Rights (2024 RSUs) (2) 06/20/2025 A 8 (2) (2) Common Shares 8 $0 42 D
Dividend Equivalent Rights (2025 RSUs) (3) 06/20/2025 A 5 (3) (3) Common Shares 5 $0 5 D
Explanation of Responses:
1. The dividend equivalent rights accrued in respect of the reporting person's deferred share units, and become exercisable and payable concurrently with the deferred share units. Each dividend equivalent right represents a contingent right to receive the economic equivalent of one RBA common share.
2. Each dividend equivalent right represents a contingent right to receive the economic equivalent of one RBA common share. The dividend equivalent rights accrued in respect of the 2024 grant of restricted share units (RSU), and become exercisable proportionately with the restricted share units to which they relate.
3. Each dividend equivalent right represents a contingent right to receive the economic equivalent of one RBA common share. The dividend equivalent rights accrued in respect of the 2025 grant of restricted share units (RSU), and become exercisable proportionately with the restricted share units to which they relate.
/s/ Maria Teresa Punsalan, attorney-in-fact for Brian Bales 06/24/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

How many shares did RB Global (RBA) director Brian Bales acquire on 20 June 2025?

He received dividend-equivalent rights covering 20 common shares (7 + 8 + 5).

Was any cash paid for the dividend-equivalent rights disclosed in the RBA Form 4?

No. The rights were credited at $0 cost as part of the equity compensation plan.

Do the newly reported rights give the director immediate voting power in RB Global?

No. They convert into common shares only when the underlying DSUs or RSUs vest.

Did the Form 4 report any sale or disposition of RB Global shares?

No sales or dispositions were reported; all transactions were acquisitions.

Is this Form 4 considered material to RB Global investors?

Given the small size (20 shares) and routine nature, it is viewed as not material.